Injection of hyaluronic acid into the joint

Booking an appointment: Required – tel. 81 532 37 11

Referral: A prior visit to the physician performing the procedure is required to qualify and select the appropriate preparation.

Age range: Depending on the doctor performing the procedure and the manufacturer's instructions.

Price-list

Chełm
  • Injection of hyaluronic acid into the joint
    350 – 800 PLN

The price depends on the type of preparation administered.


Krasnystaw
  • Injection of hyaluronic acid into the joint
    350 – 800 PLN

The price depends on the type of preparation administered.


Lublin
  • Injection of hyaluronic acid into the joint
    300 – 800 PLN

The price depends on the type of preparation administered.


Preparation

Preparation and post-treatment recommendations depend on the type of medication being administered. Your doctor will provide full details during your consultation.

Description of the study

Intra-articular injection involves inserting a needle into the affected joint to administer the preparation. The type of preparation depends on the indication and is individually selected by the physician to suit the patient's needs. The area of ​​the puncture is disinfected with a disinfectant and secured with sterile gauze pads. The physician inserts a sterile needle connected to a pre-filled syringe into the joint. A sting is felt as it penetrates the skin and subcutaneous tissue (usually the pain is mild and brief; sometimes prior anesthesia of the skin and joint capsule is necessary). After the needle is removed, the puncture site is covered with a sterile dressing, which can be removed the same day).

Indications

  • alleviating pain and joint mobility limitations resulting from post-traumatic or degenerative joint changes.

Contraindications

Contraindications depend on the type of medication being administered. Your doctor will provide full details during your consultation. The most common contraindications are:

  • hypersensitivity to hyaluronic acid and other ingredients contained in the administered preparation,
  • diagnosed systemic coagulation disorders and taking anticoagulants,
  • active tuberculosis,
  • herpetic keratitis,
  • acute psychoses,
  • systemic mycoses and parasitic infestation (strongyloid infection),
  • skin infections around the planned injection site,
  • confirmed infection of the joints to be treated,
  • cancers,
  • autoimmune pathology,
  • pregnancy and breastfeeding.